Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993-1996

被引:141
作者
Coebergh, JWW
Janssen-Heijnen, MLG
Post, PN
Razenberg, PPA
机构
[1] IKZ, Comprehens Canc Ctr S, Eindhoven Canc Registry, NL-5600 AE Eindhoven, Netherlands
[2] Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
关键词
co-morbidity; cancer; cancer registry;
D O I
10.1016/S0895-4356(99)00098-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this study was to determine the prevalence of serious concomitant conditions at diagnosis among unselected patients with cancer, increasingly older in industrialized countries. About 34,000 newly diagnosed cancer patients were recorded in the Eindhoven Cancer Registry between 1993 and 1996; subsequently data on serious co-morbidity, classified according to the Charlson scheme (J Chron Dis 1987; 40: 373-383), were collected from the clinical records by registry personnel. Co-morbid conditions were present in 12% of adult patients below 45 years of age, 28% of those 45-59 years, 53% of those 60-74 years, and 63% of patients over 75 years of age, the prevalence being highest for patients with lung (58%), kidney (54%), stomach (53%), bladder (53%), and prostate cancer (51%). Males exhibited a 10% higher prevalence than females with similar tumors. Among patients over 60 years the most frequent conditions were heart and vascular diseases (ranging across the various tumors from 10% to 30%), hypertension (11-25%), another cancer (10-20%), COPD (chronic obstructive pulmonary disease) (3-25%), and diabetes mellitus (5-25%). Inclusion of frequent co-morbid conditions in prognostic research as well as the development of specific guidelines for patient care seems warranted. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1131 / 1136
页数:6
相关论文
共 27 条
  • [1] The impact of co-morbidity on life expectancy among men with localized prostate cancer
    Albertsen, PC
    Fryback, DG
    Storer, BE
    Kolon, TF
    Fine, J
    [J]. JOURNAL OF UROLOGY, 1996, 156 (01) : 127 - 132
  • [2] BOICE JD, 1985, NIH PUBLICATION
  • [3] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [4] Prevalence of co-morbidity in newly diagnosed patients with cancer: a population-based study
    Coebergh, JWW
    Janssen-Heijnen, MLG
    Razenberg, PPA
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1998, 27 (02) : 97 - 100
  • [5] Coebergh JWW, 1995, CANC INCIDENCE SURVI
  • [6] DEMARCO MF, IN PRESS EUR J CAN
  • [7] deRijke JM, 1996, ANN ONCOL, V7, P677
  • [8] Comorbidity and functional status are independent in older cancer patients
    Extermann, M
    Overcash, J
    Lyman, GH
    Parr, J
    Balducci, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1582 - 1587
  • [9] ON CLASSIFYING CANCERS WHILE TREATING PATIENTS
    FEINSTEIN, AR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (10) : 1789 - 1791
  • [10] PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE
    FEINSTEIN, AR
    [J]. JOURNAL OF CHRONIC DISEASES, 1970, 23 (07): : 455 - +